| Financial Year |
March 31 2023 |
| Monetary Funds |
13,185,759,987.01 |
| Held-for-trading Financial Assets |
1,576,359,540.80 |
| Notes Receivable |
11,708,521.83 |
| Accounts Receivable |
2,351,575,523.35 |
| Advances to Suppliers |
861,706,095.03 |
| Other Receivables |
2,023,152,175.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
31,132,157.93 |
| Inventories |
49,719,110,616.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,314,198,763.02 |
| Total Current Assets |
82,272,051,396.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,634,712,119.28 |
| Investment Properties |
22,119,795,099.05 |
| Fixed Assetes |
3,210,835,389.29 |
| Under-construction Projects |
192,089,271.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,908,311,748.35 |
| R&D expenses |
-- |
| Goodwill |
1,569,242,919.27 |
| Long-Term Deferred and Prepaid Expenses |
335,513,548.56 |
| Deferred Income Tax Assets |
2,996,921,414.15 |
| Other Non-Current Assets |
1,076,859,853.57 |
| Sub-Total of Non-Current Assets |
48,382,573,589.69 |
| Total Assets |
130,654,624,986.43 |
| Short-Term Loans |
7,472,828,313.41 |
| Trading Financial liabilities |
4,420,622,200.00 |
| Notes Payable |
21,846,188.66 |
| Accounts Payable |
8,425,961,816.93 |
| Accounts Received In Advance |
59,244,593.62 |
| Employee Compensation Payable |
357,093,908.00 |
| Taxes Payable |
7,194,888,206.49 |
| Interest Payable |
-- |
| Dividend Payable |
23,726,991.72 |
| Other payables |
6,642,190,474.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,882,699,696.19 |
| Other Current Liabilities |
1,254,251,913.32 |
| Sub-Total of Current Liabilities |
62,529,896,036.58 |
| Long-term Loans |
23,182,633,391.62 |
| Bonds Payable |
800,900,000.00 |
| Long-Term Accounts Payable |
173,027,462.32 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,472,542,305.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,189,089,736.85 |
| Total Liabilities |
90,718,985,773.43 |
| Paid-In Capital(Or Share Stock) |
3,899,930,914.00 |
| Capital Surplus |
8,685,864,036.12 |
| Surplus Reserve |
2,366,927,318.05 |
| LESS:Treasury Stock |
311,866,083.04 |
| Undistributed Profits |
20,273,503,358.61 |
| Minority Stockholder's Interest |
3,922,876,876.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
36,012,762,336.48 |
| Owner's Equity（Stockholder's Equity） |
39,935,639,213.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
130,654,624,986.43 |
